TY - JOUR A1 - Huang, Jiebo A1 - Yu, Qing A1 - Chen, Sheng T1 - Level changes of adiponectin and cd146 in serum in type 2 diabetic nephropathy Y1 - 2014/7/1 JF - Journal of Integrative Nephrology and Andrology JO - J Integr Nephrol Androl SP - 33 EP - 37 VL - 1 IS - 1 UR - http://www.journal-ina.com/article.asp?issn=2394-2916;year=2014;volume=1;issue=1;spage=33;epage=37;aulast=Huang DO - 10.4103/2225-1243.137552 N2 - Objective: The aim was to observe the level changes of adiponectin (ADPN) and CD146 in serum and clarify the properties of these peptides in patients with type 2 diabetic nephropathy (DN). Materials and Methods: Seventy-five patients with type 2 diabetes and 13 control subjects included in this study. Levels of ADPN and CD146 in serum were measured by enzyme-linked immunosorbent assay. Results: The serum level of ADPN was higher in patients with diabetes than that in controls, and it increased significantly in the DN1 group. The serum level of CD146 was considerably higher in the DN1 group than that in the other groups. The serum level of ADPN was positively correlated with the serum level of CD146 and body mass index in diabetics. The serum level of ADPN in 54 patients with diabetes and vascular atherosclerosis was significantly lower than that in 21 patients without vascular atherosclerosis. However, there was a definite relationship between the serum levels of ADPN and CD146. Conclusion: The serum levels of ADPN and CD146 appear to increase in patients with early DN and decrease in the final stage of DN. Serum ADPN and CD146 may protect against vascular endothelial dysfunction and mitigate endothelial dysfunction in DN. Further study is required to elucidate the exact role of ADPN and CD146 in the progression of vascular complication in DN. ER -